Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Ischemic Heart Disease

Free Subscription 08.12.2025 2 Am J Cardiol 1 Angiology 1 Ann Intern Med 1 Arterioscler Thromb Vasc Biol 1 Can J Cardiol 1 Catheter Cardiovasc Interv 1 Circ Cardiovasc Imaging 1 Circ Res 4 Circulation 2 Clin Cardiol 2 Clin Chem 2 Crit Care Med 1 Eur Heart J 1 Hypertension 9 Int J Cardiol 5 J Am Coll Cardiol 1 J Clin Invest 2 J Mol Cell Cardiol 1 J Thorac Cardiovasc Surg 1 Lancet 1 Mayo Clin Proc 1 Mol Cell Biochem 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. GHAY S, Saini AS, Kaur B, Vera AA, et al
   Hospitalization Outcomes After Acute Myocardial Infarction in Patients With Prior Thoracic Irradiation.
   Am J Cardiol. 2025 Nov 30:S0002-9149(25)00694.
   PubMed         Abstract available
   
   
2. PHAGU AAS, van Oort MJH, Oliveri F, Bingen BO, et al
   Intravascular Lithotripsy in Diabetic Patients Undergoing Percutaneous Coronary Intervention: Long-Term Outcomes from the BENELUX Registry.
   Am J Cardiol. 2025 Nov 27:S0002-9149(25)00691.
   PubMed         Abstract available
   
   

   
   Angiology

3. MOVAHED MR
   Strongly Recommend Percutaneous Coronary Intervention for Any Chronic Total Occlusion (CTO) Based on a Secondary Analysis is Very Misleading.
   Angiology. 2025 Nov 30:33197251399867. doi: 10.1177/00033197251399867.
   PubMed        
   
   

   
   Ann Intern Med

4. MEI DA, Romiti GF
   In patients with chronic coronary syndrome and high atherothrombotic risk, adding aspirin to OAC increased adverse CV events at 2 y.
   Ann Intern Med. 2025 Dec 2. doi: 10.7326/ANNALS-25-04685.
   PubMed         Abstract available
   
   

   
   Arterioscler Thromb Vasc Biol

5. ZHANG B, Furtado JD, Andraski AB, Guglielmo B, et al
   Partially Replacing Dietary Carbohydrate With Unsaturated Fat or Protein Shifts Protein-Based HDL Subspecies Toward Lower Coronary Heart Disease Risk.
   Arterioscler Thromb Vasc Biol. 2025 Dec 2. doi: 10.1161/ATVBAHA.125.323709.
   PubMed         Abstract available
   
   

   
   Can J Cardiol

6. OKA S, Takemura K, Takefuji Y
   Feature Importance Bias: Addressing Interpretability Issues in Tree-Based Acute Myocardial Infarction Risk Models.
   Can J Cardiol. 2025 Nov 27:S0828-282X(25)01475.
   PubMed        
   
   

   
   Catheter Cardiovasc Interv

7. GU F, Chen Z, Lu Y, Chen S, et al
   Short-Term Thrombosis Following Coronary Stent Implantation in a Patient With Myocardial Infarction and COVID-19 Infection: A Case Report and Literature Review.
   Catheter Cardiovasc Interv. 2025 Dec 2. doi: 10.1002/ccd.70398.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Imaging

8. HYAFIL F, Mikail N
   Myocardial Perfusion Imaging in Patients After Coronary Artery Bypass Grafting: Should We Go With the Flow?
   Circ Cardiovasc Imaging. 2025 Dec 2:e019207. doi: 10.1161/CIRCIMAGING.125.019207
   PubMed        
   
   

   
   Circ Res

9. HUME RD, Warwick J, Shim WJ, Malecki C, et al
   Human Hearts Intrinsically Increase Cardiomyocyte Mitosis After Myocardial Infarction.
   Circ Res. 2025 Dec 4. doi: 10.1161/CIRCRESAHA.125.327486.
   PubMed         Abstract available
   
   

   
   Circulation

10. TSIMIKAS S, Szarek M, Cobbaert CM, Romijn F, et al
    Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes after Acute Coronary Syndrome.
    Circulation. 2025 Dec 1. doi: 10.1161/CIRCULATIONAHA.125.073855.
    PubMed         Abstract available
    
    
11. TOMCZYK M, Kraszewska I, Li G, Hayes MJ, et al
    Chordin-Like 1 mRNA Therapy for Acute Myocardial Infarction.
    Circulation. 2025;152:1586-1589.
    PubMed        
    
    
12. RAJKUMAR CA, Foley MJ, Ahmed-Jushuf F, Chotai S, et al
    The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study.
    Circulation. 2025;152:1541-1551.
    PubMed         Abstract available
    
    
13. FETTERMAN JL, Chinnery PF, McClellan R, Wallace DC, et al
    Mitochondrial Genetics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Dec 2. doi: 10.1161/CIR.0000000000001393.
    PubMed         Abstract available
    
    

    
    Clin Cardiol

14. GAO Y, Shi Q, Shi Z, Zhang Z, et al
    Impact of Insomnia on Myocardial Infarction Risk and Coronary Plaque Vulnerability: Insights From Mendelian Randomization and OCT Imaging.
    Clin Cardiol. 2025;48:e70226.
    PubMed         Abstract available
    
    
15. WAJEEH SAQIB H, Khan T, Bashir R, Hayat T, et al
    Leave Nothing Behind in Coronary Intervention: Time to Move From Promise to Proof.
    Clin Cardiol. 2025;48:e70228.
    PubMed        
    
    

    
    Clin Chem

16. PARASHAR Y, Awwad A, Bagchi S, Claggett B, et al
    A Meta-Analysis and Systematic Review of Cardiac Troponin I vs T in Community Dwelling Adults: Is Specificity at Risk?
    Clin Chem. 2025;71:664-676.
    PubMed         Abstract available
    
    
17. SAEED N, Restan IZ, Steiro OT, Tjora HL, et al
    Analytical Error of Cardiac Troponin and Impact on the Performance of Accelerated Diagnostic Protocols in Patients with Acute Chest Pain.
    Clin Chem. 2025;71:1243-1256.
    PubMed         Abstract available
    
    

    
    Crit Care Med

18. THEVATHASAN T, Alyahoud M, Freund A, Akin I, et al
    Extracorporeal Membrane Oxygenation Complications Are Not Causal for Mortality in Patients With Infarct-Related Cardiogenic Shock: A Mediation Analysis of the Extracorporeal Life Support in Infarct-Related Cardiogenic Shock (ECLS-SHOCK) Trial.
    Crit Care Med. 2025;53:e2607-e2617.
    PubMed         Abstract available
    
    
19. FENG SN, Liu WL, Kang JK, Kalra A, et al
    Impact of Left Ventricular Venting on Acute Brain Injury in Patients With Cardiogenic Shock: An Extracorporeal Life Support Organization Registry Analysis.
    Crit Care Med. 2025 Oct 17. doi: 10.1097/CCM.0000000000006897.
    PubMed         Abstract available
    
    

    
    Eur Heart J

20. KIRMES K, Han J, Klug M, Bloxham CJ, et al
    Reticulated platelets in coronary artery disease: a multidimensional approach unveils prothrombotic signalling and novel therapeutic targets.
    Eur Heart J. 2025;46:4901-4917.
    PubMed         Abstract available
    
    

    
    Hypertension

21. KARIO K, Alkatiri AA, Aoki J, Ahmad WAW, et al
    Renal Denervation in Asia: 2025 Asia Renal Denervation Consortium (ARDeC) Consensus Statement Endorsed by the Hypertension Cardiovascular Outcome Prevention and Evidence in Asia (HOPE Asia) Network.
    Hypertension. 2025 Dec 2. doi: 10.1161/HYPERTENSIONAHA.125.25333.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

22. BESUTTI M, Guillon B, Barthod C, Ecarnot F, et al
    Diagnostic yield of referring patients for invasive coronary angiography primarily based on high CAC scores: Positive predictive value for obstructive coronary artery disease in a consecutive real-life cohort.
    Int J Cardiol. 2026;444:133979.
    PubMed         Abstract available
    
    
23. RACHWAN RJ, Chehab O, Bou Chaaya RG, Daher G, et al
    A simple clinical scoring model to predict significant left main/three-vessel disease in non-ST elevation acute coronary syndrome: The MADISON score.
    Int J Cardiol. 2025 Oct 26:133976. doi: 10.1016/j.ijcard.2025.133976.
    PubMed         Abstract available
    
    
24. PAPAZOGLOU AS, Tsiartas E, Kyriakoulis KG, Moysidis DV, et al
    Prevalence and clinical impact of baseline atherosclerotic vascular disease in patients undergoing transcatheter aortic valve implantation: A meta-analysis.
    Int J Cardiol. 2025;444:134004.
    PubMed         Abstract available
    
    
25. PEREA-ARMIJO J, Herrera-Flores J, Suarez de Lezo-Herreros de Tejada J, Hidalgo-Lesmes FJ, et al
    Inverted provisional in the left main: A therapeutic alternative in ostial circumflex lesions.
    Int J Cardiol. 2026;444:133994.
    PubMed         Abstract available
    
    
26. CHERBI M, Roubille F, Lamblin N, Puymirat E, et al
    Cardiogenic shock: Who benefits from heart replacement therapy?
    Int J Cardiol. 2026;444:134003.
    PubMed         Abstract available
    
    
27. MOLNAR D, Knuuti J, Bax JJ, Saraste A, et al
    Sex differences in plaque burden and outcomes in symptomatic patients with suspected coronary artery disease.
    Int J Cardiol. 2026;444:134023.
    PubMed         Abstract available
    
    
28. NOGAMI K, Ozcan I, Kanaji Y, Gulati R, et al
    Long-term temporal trend in plaque eccentricity assessed through intravascular ultrasound imaging after heart transplantation.
    Int J Cardiol. 2025;444:134022.
    PubMed         Abstract available
    
    
29. CANEDO E, Carrillo-Suarez X, Fernandez-Nofrerias E, Rodriguez-Leor O, et al
    Association between activated clotting time and TIMI flow in STEMI patients pre-treated with unfractionated heparin.
    Int J Cardiol. 2026;444:134007.
    PubMed         Abstract available
    
    
30. DE LUCA L, Raone L, Rosato S, D'Errigo P, et al
    The prognostic role of cardiology management during index admission for acute myocardial infarction: A nationwide administrative dataset analysis.
    Int J Cardiol. 2025 Nov 28:134069. doi: 10.1016/j.ijcard.2025.134069.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

31. DAMLUJI AA, Nanna MG, Menon V
    Frailty in Cardiovascular Disease: Time for a Universal Definition!
    J Am Coll Cardiol. 2025 Dec 3:S0735-1097(25)10032.
    PubMed        
    
    
32. MORAN AE, Apeagyei AE, Shyong C, Elliott H, et al
    Global Development Assistance for Health Allocated to Cardiovascular Disease Control, 2015 to 2022.
    J Am Coll Cardiol. 2025;86:2388-2390.
    PubMed        
    
    
33. KOHSAKA S, Kumamaru H, Sawano M, Mori M, et al
    Nationwide Trends in Coronary Revascularization in Japan, 2017 to 2023: From Decline to Plateau.
    J Am Coll Cardiol. 2025;86:2391-2394.
    PubMed        
    
    
34. HAKEEM A, Shah JA, Kumar R, Ali A, et al
    Twice-Daily Clopidogrel vs Ticagrelor to Reduce Short-Term Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention: The TADCLOT Trial.
    J Am Coll Cardiol. 2025;86:2330-2345.
    PubMed         Abstract available
    
    
35. DANILOV A, Duran-Luciano P, Yuan Y, De Oliveira Gomes D, et al
    Association of Lp(a) With Cardiovascular Disease and All-Cause Mortality in U.S. Hispanics and Latinos.
    J Am Coll Cardiol. 2025;86:2292-2310.
    PubMed         Abstract available
    
    

    
    J Clin Invest

36. RUSCHITZKA F, Vidal-Puig A, Saeedi Saravi SS
    Gut microbial metabolite connections to cardiovascular disease call for gutsy therapeutic approaches.
    J Clin Invest. 2025;135:e201468.
    PubMed        
    
    

    
    J Mol Cell Cardiol

37. ZHAO L, Cao Y, Liu X, Yang Q, et al
    ZIP14 upregulation leads to ferroptosis and lysosomal dysfunction through intracellular iron overload and induces myocardial ischemia/reperfusion injury in mouse hearts.
    J Mol Cell Cardiol. 2025 Nov 27:S0022-2828(25)00219.
    PubMed         Abstract available
    
    
38. SANCHEZ-LOPEZ D, Garcia-Vega D, Vinuela JE, Ferreiros-Vidal I, et al
    Corrigendum to 'FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil's proatherogenic phenotype which is modulated by semaglutide' [Journal of Molecular and Cellular Cardiology volume 210 (2026) 12-27].
    J Mol Cell Cardiol. 2025;211:63.
    PubMed        
    
    

    
    J Thorac Cardiovasc Surg

39. MUIR KC, Harris DD, Stone C, Kanuparthy M, et al
    Linagliptin exerts a sex-specific effect on cardiac function, collateralization, and metabolism in a swine model of cardiometabolic disease.
    J Thorac Cardiovasc Surg. 2025 May 3:S0022-5223(25)00306.
    PubMed         Abstract available
    
    

    
    Lancet

40. VAN DER BIJL P, Gulati M, Saraste A, Marwick T, et al
    Contemporary, non-invasive imaging diagnosis of chronic coronary artery disease.
    Lancet. 2025;406:2577-2587.
    PubMed         Abstract available
    
    

    
    Mayo Clin Proc

41. 
    Corrigendum to 'The Impact of Lipid-Lowering Combination Therapy of Statins and Ezetimibe vs Statin Monotherapy on the Reduction of Cardiovascular Outcomes: A Meta-Analysis' [Mayo Clinic Proceedings, Article in Press, https://doi.org/10.1016/j.mayocp.
    Mayo Clin Proc. 2025;100:2279.
    PubMed        
    
    

    
    Mol Cell Biochem

42. CHAUHAN R, Lidoo K, Jyoti U, Singh TG, et al
    Decoding the gut microbiota-mitochondrial-inflammasome axis in cardiovascular disease.
    Mol Cell Biochem. 2025 Dec 1. doi: 10.1007/s11010-025-05451.
    PubMed         Abstract available
    
    

    
    PLoS One

43. ARNEJA M, Gunasekar S, Narayanan DH, Joseph J, et al
    Single catheter strategy for transradial angiography and primary percutaneous coronary intervention enhances procedural efficiency, microvascular outcomes, and cost-effectiveness: Implications for STEMI healthcare in resource-limited settings.
    PLoS One. 2025;20:e0337841.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.